Average Co-Inventor Count = 6.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (30 from 2,405 patents)
30 patents:
1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
2. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
3. 12297208 - Small molecule inhibitors of KRAS G12C mutant
4. 12291538 - Small molecule inhibitors of KRAS G12C mutant
5. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
6. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
7. 11697657 - Small molecule inhibitors of KRAS G12C mutant
8. 11358711 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
9. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
10. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
11. 11104690 - Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
12. 10947222 - Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
13. 10934312 - Tricyclic heterocycle compounds useful as HIV integrase inhibitors
14. 10829499 - Tetracyclic heterocycle compounds useful as HIV integrase inhibitors
15. 10624912 - Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors